Login / Signup
Reply to the Letter to the editor "Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD".
Hirokazu Takahashi
Keizo Anzai
Published in:
Hepatology communications (2022)
Keyphrases
</>
type diabetes
adipose tissue
glycemic control
insulin resistance
weight loss